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Data support extended use of levonorgestrel intrauterine systems
Editor—The levonorgestrel intrauterine
system (Mirena), a useful addition to contra›
ceptive choice, is now approaching its third
anniversary.
In the United Kingdom the product
licence for the levonorgestrel intrauterine
system permits its use for three years. In all
other countries where the system is mar›
keted, however, its use is approved for five
years. There is good evidence to support this
longer duration,1 and indeed the system
seems to remain effective for as long as
seven years.2 We understand that Schering
Healthcare has applied for a two year exten›
sion to its current licence, backed by their
new data that relates to the new polymer
that has been used since 1990.
Many clinicians have asked us if they
should conform strictly to the current prod›
uct licence and replace each intrauterine
system on the third anniversary of its
insertion. We would strongly advise delaying
reinsertion in this time, at least until the
expected statement from the Medicines
Control Agency.
It is well known that the process of inser›
tion of all intrauterine contraceptives causes
problems (short term inconvenience and dis›
comfort followed by new bleeding and pain
or expulsion) and also real risks,3 4 notably
perforation and upper genital tract infection.
These would be unacceptable if it emerges
that reinsertions were not necessary.
Users of the levonorgestrel intrauterine
system can be reassured that good data are
available to support its use for five years. From
15 May, and until any statement concerning a
change in the licence, continuation beyond
three years is legitimate, at the woman’s
choice, provided the established criteria for
use by named patients are observed—that is,
explaining that this is unlicensed use of a
licensed product; highlighting the risks and
benefits of the proposed non›intervention;
obtaining and recording the woman’s verbal
consent in her case notes; and keeping a
separate record of the woman’s name and the
nature of the unlicensed use.5
Diana Mansour Medical advisor
Margaret Pyke Memorial Trust, London W1P 1LB
John Guillebaud Medical director
Margaret Pyke Family Planning Centre, London
W1P 1LB
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Are sex and death related?
Study failed to adjust for an important
confounder
Editor—Davey Smith et al report a signifi›
cant inverse relation between frequency of
orgasm and mortality due to all causes and
coronary heart disease in men; however, a
failure to adjust for the energy expended
during sexual activity may be a weakness of
their work.1 The intensity level of sexual
activity is equivalent to that of leisurely walk›
ing or strolling,2 and an increasing level of
energy output, even when amassed during
walking, is independently associated with a
decreased risk of all cause mortality.3 This
failure to adjust for the energy cost of sexual
activity may be amplified if, as seems plausi›
ble, the more sexually active individuals have
a stronger disposition to physical activity per
se than their less virile counterparts.
David Batty Researcher
University of Bristol, Exercise and Health Research
Unit, Woodland House, Bristol BS8 2LU
1 Davey Smith G, Frankel S, Yarnell J. Sex and death: are
they related? Findings from the Caerphilly cohort study.
BMJ 1997;315:1641›5. (20›27 December.)
2 Ainsworth BE, Haskell WL, Leon AR, Jacobs DR, Montoye
HJ, Sallis JF, et al. Compendium of physical activities: clas›
sification of energy costs of human physical activities. Med
Sci Sports Exerc 1993;25:71›80.
3 Hakim AA, Petrovitch H, Burchfiel CM, Ross GW,
Rodriguez BL, White LR, et al. Effects of walking on mor›
tality among nonsmoking retired men. N Engl J Med
1998;338:94›9.
Study did not treat sexual behaviour with
the importance it deserves
Editor—The article by Davey Smith et al on
sexual behaviour and mortality was a disap›
pointment.1 The topic is important, and the
results should at least be correct. I was
surprised by the simplistic design, the
mechanical interpretation of the results, and
the selective use of references—even from
the Holy Bible.2 Although long term follow
up studies have to cope with shifts in
medical thinking by the time of publication,
this should have been addressed in the
discussion. Even in the late seventies, during
the time of the study’s design, psychological
understanding of human sexuality was
rather more complex than the authors
imply. Firstly, not even minimal information
on partners or relationships was included.
Indeed, marital status was not mentioned
and they gave no reason for this, despite
numerous published studies on the relation
between mortality and marital status before
and since the seventies.3 4 It is likely that
those men who had regular sexual activity in
late middle age were either married or in
long term relationships. The greater longev›
ity of married compared with unmarried
people has been shown repeatedly5 and this
might be an important confounding factor.
Secondly, it was naive to use the term sexual
intercourse and orgasm interchangeably. If
the authors were mainly interested in the
health effect of orgasm, as a purely
biological phenomenon, surely masturba›
tion should not have been ignored. Thirdly,
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it is unlikely that sexual behaviour is static.
As Hotopf and Wessely pointed out in their
comment, sexual activity is influenced by
age, health factors, and psychopathology.1
To these might be added changes in
relationships, loss of spouse etc, which were
not addressed, implying that the authors
believe one self report measure is adequate
to describe a person’s sexual activity during
an entire lifetime, or at least from the age of
45 to death. Given these shortcomings, the
authors should have been more cautious in
their conclusions. The only message from
this study is that the topic needs further (and
more sophisticated) investigation. Inventing
new health promotion slogans with numeri›
cal imperatives would be premature and
should certainly be withheld.
Agnes Ayton Specialist registrar in child and
adolescent psychiatry
Lime Trees Child, Adolescent and Family Unit,
York YO3 ORE
1 Davey Smith G, Frankel S, Yarnell J. Sex and death: are
they related? Findings from the Caerphilly cohort study.
BMJ 1997;315:1641›5. [With commentary by M Hotopf
and S Wessely.] (20›27 December.)
2 Holy Bible. I Corinthians vii, 2›5.
3 Berkson J. Mortality and marital status: reflection on the
derivation of etiology from statistics. Am J Public Health
1962;52:1318›29.
4 Goodwin JS, Hunt W, Key R, Samet JM. The effect of mari›
tal status on stage, treatment, and survival of cancer
patients. JAMA 1987;258:3125›30.
5 Chandra V, Szklo M, Goldberg R, Tonascia J. The impact of
marital status on survival after myocardial infarction: a
population based study. Am J Epidemiol 1983;117:320›5.
Author’s reply
Editor—Our report on the association
between sexual behaviour and mortality was
intended to illustrate the findings that
associational epidemiological studies can
produce.1 This information adds to earlier
publications on the subject,2 which we did
make clear in the discussion. The findings
have interest beyond this, however, and we
would welcome further investigations. We
agree with Batty that attention should be
paid to physical activity, but conceptual clar›
ity needs to be maintained when this is done.
Batty states that we failed to adjust for physi›
cal activity, which he considers an important
confounder. It is possible that men engaging
in lots of sexual activity also participate in
other forms of physical activity. Adjusting
for energy expended during sexual activity,
as suggested by Batty, would not be
adjusting for confounding as the physical
activity involved in sexual encounters could
be the protective factor and, therefore, an
integral part of the exposure. Investigation
of this issue would be complex. Although
Batty explains that the exertion of sexual
activity is equivalent to that of leisurely walk›
ing or strolling, this would be different for
adventurous couplings.
Our article was intended to fit in with the
festive cheer of the BMJ 3 4 and to provide an
introduction to associational findings in epi›
demiological studies. Ayton has missed both
these points. The majority of our men were
married and the results were identical if we
restricted the analysis to married men. Our
reference to health education was intended
to be ironic, not least because the benefits
exceeded those anticipated with most estab›
lished health promotion programmes.
Some readers obviously missed this mild
mischief. In future, to spare disappointment
at the end of the year perhaps Ayton should
avoid the Christmas BMJ.
George Davey Smith Professor of clinical
epidemiology
Department of Social Medicine, University of
Bristol, Bristol BS 2PR
1 Davey Smith G, Frankel S, Yarnell J. Sex and death: are
they related? Findings from the Caerphilly cohort study.
BMJ 1997;315:1641›5. (20›27 December.)
2 Davey Smith G, Phillips AN, Neaton JD. Smoking as “inde›
pendent” risk factor for suicide: illustration of an artefact
from observational epidemiology? Lancet 1992;340:709›
12.
3 Cleare AJ, Wessely SC. Just what the doctor ordered—more
alcohol and sex. BMJ 1997;315:1637›8.
4 White IR, McKee M. Festive cheer for all? BMJ 1997;315:
1638›9.
Cancer in the offspring of
radiation workers
Connection between leukaemia and
radiation needs to be considered
Editor—The results of the study of Draper et
al showing an association between worker
status of parents and leukaemia in children1
are unlikely to be attributable to chance.
Some exposure to a causative agent, either at
the workplace of male radiation workers or in
the communities to which they belong, must
increase the risk of childhood leukaemia.
Draper et al suggest an oncogenic infec›
tious agent that results from high rates of
population mixing as the cause of increased
leukaemia risk. Their evidence is based on
three factors: an association of population
mixing with childhood leukaemia; popula›
tion mixing in the vicinity of certain nuclear
sites; and worker migration between sites.
These factors do not explain the excess risk
of 80%. A review of all the studies published
at that time of childhood leukaemia in areas
with high population mixing2 gave 50% as
best estimate of increased risk, with only one
having an estimate as high as 80%.
The effects of population mixing, how›
ever, may be diluted in these workers for
several reasons. Firstly, only a proportion
will have been employed at establishments
such as Sellafield. Secondly, the time
windows of documented excess mixing near
these plants are mostly short relative to the
34 years of this study. Thirdly, radiation
worker status of the father before concep›
tion of the child is, here, an inaccurate meas›
ure of the relevant exposure (which presum›
ably occurs after conception). Nevertheless,
given the accumulating evidence that links
patterns of exposure to infectious agents
with childhood leukaemia,2 3 an infectious
origin for this excess should be considered.
So, I suggest, should a connection with
radiation. Maybe an additional factor that
applies to communities of radiation workers
has the same effect as population mixing—
that is, to favour microepidemics of the puta›
tive agent. The possible relevance of immu›
notoxic properties of ionising radiation in
individual people has been proposed.4 The
community effect on herd immunity can be
much larger than the sum of small individual
parts5 and could apply here. Immunosup›
pression of a human population would
increase the risk of microepidemics by
increasing the probability of infection after a
single contact. In addition, for agents that
establish latency it would increase the
number of infectious people. Mild immuno›
suppression of the population may be
another mechanism in communities that
increases the risk of childhood leukaemia.
Case and control fathers1 should now be
linked to National Registry of Radiation
Workers records to determine radiation
worker status after conception. Also linked,
if possible, should be examination of contact
between the fathers (employment at the
same site at the same time), especially at
critical periods such as gestation, the first
year of life, and the year preceding
diagnosis.
Freda Alexander Reader in cancer epidemiology
University of Edinburgh, Department of Public
Health Sciences, Edinburgh EH8 9AG
1 Draper GJ, Little MP, Sorahan T, Kinlen LJ, Bunch KJ,
Conquest AJ, et al. Cancer in the offspring of radiation
workers: a record linkage study. BMJ 1997;315;1181›9.
(8 November.)
2 Kinlen LJ. Epidemiological evidence for an infective basis
in childhood leukaemia. Br J Cancer 1995;71:1›5.
3 Greaves MF. Aetiology of acute leukaemia. Lancet 1997;
349:344›9.
4 Alexander FE. Viruses, clusters and clustering of
childhood leukaemia: a new perspective? Eur J Cancer
1993;29:1424›43.
5 Starr JM, Rogers TR, Impallomeni M. Hospital›acquired
Clostridium difficile diarrhoea and herd immunity. Lancet
1997:349:426›8.
Exposure to internal radioisotopes may
be responsible
Editor— Draper et al find a 1.8›fold excess
relative risk for leukaemia in children of
male radiation workers and a fivefold
relative risk in children of female workers.1
Since the highest risk does not follow the
highest dose they conclude that exposure to
radiation is not the cause of the leukaemia
and that the Gardner hypothesis is refuted.
This conclusion is unwarranted because
exposure to internal radioisiotopes may be
responsible.
Gardner was well aware that the external
irradiation studies were at odds with his
findings and wrote: “The interpretation [of
our findings] in terms of a related causal
mechanism is not known . . . the examination
of radionuclides and other occupational
exposures is under way.”2
Roman et al studied children of radia›
tion workers in west Berkshire and drew dif›
ferent conclusions when they found a
2.2›fold excess risk of leukaemia:“The possi›
bility that the effects could be due to internal
contamination by radioactive substances . . .
should be explored.”3
This was done by Rooney et al for risk of
prostate cancer in nuclear workers.4 The
excess risk had not followed a simplistic
dose›response relation with external film
badge doses, and the researchers could have
concluded, like Draper et al, that ionising
radiation was not the cause of cancer.
Instead, they looked at internal contamina›
Letters
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tion and found significant evidence for
enhancement of hazard as a result of
internal exposure to a number of isotopes—
for example, a relative risk of 14.2 for
tritium. This suggests an error of more than
500 times in the current risk of prostate can›
cer based on Hiroshima.5 It is unsafe to
assume that the excess risk of leukaemia is
any different from the risk of prostate cancer
without investigating this further.
In fact, Draper et al’s study found an
increased relative risk of 2.5 times for
radiation workers who had been monitored
for internal exposure, compared with 1.6 for
those who had not been monitored. If
internal radiation is the cause, then the true
relative risks are far higher since the controls
used by Draper et al were from local popula›
tions whose risk of internal contamination is
higher than that of the general population.
Finally, Draper et al assert that although
the increased risks exist they are small in
absolute terms: the risk of 6.5 per 10 000 (an
error, presumably they mean per 100 000)
increases by 5.4 to 11.9. This means that
many children have died because their
parents worked in the nuclear industry. No
one should be comforted by how low the
absolute numbers were.
Cris Busby Researcher
Molly Scott Cato Researcher
Green Audit, Aberystwyth SY23 1PU
1 Draper GJ, Little MP, Sorahan T, Kinlen LJ, Bunch KJ,
Conquest AJ, et al. Cancer in the offspring of radiation
workers: a record linkage study. BMJ 1997;315:1181›8.
(8 November.)
2 Gardner MJ, Leukemia in children and paternal radiation
exposure at the Sellafield nuclear site. J Natl Cancer Inst
1992;No 12:133›5. (Monograph.)
3 Roman E, Watson A, Beral V, Buckle S, Bull D, Baker K, et
al. Case›control study of leukaemia and non›Hodgkin’s
lymphoma among children aged 0›4 years living in west
Berkshire annd north Hampshire health districts. BMJ
1993;306:615›21.
4 Rooney C, Beral V, Moconochie N, Fraser P, Davies G.
Case›control study of prostatic cancer in employees of the
United Kingdom Atomic Energy Authority. BMJ 1993;
307:1391›7.
5 Busby C. Increase in cancer in Wales unexplained, BMJ
1993;308:268.
Combination of antibiotics and non›fatal
infections may be responsible for higher
number of deaths from leukaemia
Editor—Draper et al1 say that the most
likely explanation for the excess of child›
hood leukaemia at Seascale seems to be
infection promoted by population mixing,
and they refer their readers to the Kinlen
hypothesis.2 According to this hypothesis,
leukaemia is a rare response to a widespread
virus infection that only needs a large influx
of people into a previously isolated place to
produce an epidemic.
The existence of such viral epidemics is
not in dispute. According to the Oxford sur›
vey of childhood cancers, however, children
who die from leukaemia before they reach
the age of 16 are abnormally sensitive to
infection throughout their lifespan,3 and, in
relation to leukaemia, pneumonia and other
serious infections may be either competing
causes of death4 or promoters of the
neoplastic process.5
According to the survey, viral epidemics
caused by population mixing might reduce
the frequency of leukaemia by adding to the
number of children who die before they
show any signs of malignant disease. Nowa›
days, however, antibiotics save lives while
non›fatal infections are known to promote
cancer. As a result of this combination of
factors, epidemics would probably have the
opposite effect. The second alternative
would not rule out a viral origin for leukae›
mia, but it offers a much simpler explanation
of the Seascale cluster than the one
advanced by Kinlen.
Alice Stewart Emeritus fellow
Leverhulme Trust, University of Birmingham,
Department of Public Health and Epidemiology,
Birmingham B15 2TT
1 Draper GJ, Little MP, Sorahan T, Kinlen LJ, Bunch KJ,
Conquest AJ, et al. Cancer in the offspring of radiation
workers: a record linkage study. BMJ 1997;315:1181›8.
(8 November.)
2 Kinlen LJ. Evidence of an infectious cause of childhood
leukaemia. Lancet 1988;ii;1323›7.
3 Stewart AM, Kneale GW. The immune system and cancers
of foetal origin.Cancer Immunol Immunother 1982;14:110›6.
4 Kneale GW. Excess sensitivity of pre›leukaemics to
pneumonia. A model situation for studying the interaction
of an infectious disease with cancer. Br J Prev Soc Med
1971;25:152›9.
5 Kneale GW, Stewart AM. Childhood cancers in the UK
and their relations to background radiation. Radiation and
Health 1987;16:203›20.
Authors’ reply
Editor—Alexander draws attention to the
fact that the excess of childhood leukaemia
in our study is slightly higher than in most
population mixing studies.
A point that deserves to be considered is
the difference in design. Previous studies
have covered total populations of certain
areas, whereas ours concerned the industry
in which the mixing was concentrated. It is
therefore relevant that a marked excess of
leukaemia among the children of men in
another (the construction) industry has
recently been reported in areas of marked
rural population mixing, and it is higher
than that in radiation workers.1 We are not
aware of any evidence to suggest that
Alexander’s immunotoxic hypothesis is
relevant to our findings. We agree with the
suggestion about examining the links
between cases of childhood cancer and
radiation workers with exposures after
conception; in fact, this has already been
under discussion.
Busby and Cato misquote us. Firstly, we
did not say that the Gardner hypothesis is
refuted, merely that our results do not
support it. Secondly, they have changed the
tenor of our comment about risks. The issue
here is, however, that it is important to
present the absolute risks—neither exagger›
ating the results nor downplaying them—
and to avoid the misunderstandings that can
occur when only relative risks are quoted for
rare diseases. (The denominators for the
absolute risks that we quoted are correct.)
The possibility that Gardner’s results were
due to internally deposited radionuclides
was considered in detail in the studies by the
Health and Safety Executive that we quoted,
but no support was found. These and other
findings in relation to internally deposited
radionuclides are discussed in our paper
and in the full report referred to there.
We agree with Stewart that all plausible
mechanisms should be considered to
explain how any infective agent might influ›
ence the incidence of childhood malignancy.
G J Draper Director
Childhood Cancer Research Group, University of
Oxford, Oxford OX2 6HJ
M P Little Principal scientific officer
National Radiological Protection Board, Chilton,
Didcot OX11 0RQ
T Sorahan Reader in occupational epidemiology
Institute of Occupational Health, University of
Birmingham, Birmingham B15 2TT
L J Kinlen Director
Cancer Research Campaign, Cancer Epidemiology
Research Group, Department of Public Health,
Radcliffe Infirmary, University of Oxford, Oxford
OX2 6HE
1 Kinlen LJ. High›contact paternal occupations, infection
and childhood leukaemia: five studies of unusual
population›mixing of adults. Br J Cancer 1997;76;1539›45.
Cognitive impairment and
survival in very elderly people
Mini›mental state examination may not
test cognitive function adequately
Editor—Gussekloo et al hypothesised that
mild cognitive impairment as determined by
the Dutch version of the mini›mental state
examination discriminates subjects with a
higher risk of mortality.1
We have concerns about the validity of
using the mini›mental state examination as
an adequate test of cognitive function. We
have doubts about the reproducibility of test
scores if the test is administered by different
physicians. In clinical practice the mini›
mental state examination is well recognised
as being a useful guide rather than an abso›
lute measure of cognitive function; it is a
subjective test with variable results.
In particular, we think that defining the
scores for mild cognitive impairment and
normal cognitive function so close together,
at 24›27 and 28›30 respectively, is a
potential source of bias. A subject could fall
into either category, depending on several
variables affecting alertness, such as time of
day, timing of drug treatment, stress, and
discomfort.
The authors conclude that this test
“seems to be useful as a screening instru›
ment for mild cognitive impairment, and its
scores may act as an important predictor of
survival in very elderly people.”1 Although
this conclusion may be valid, we question the
usefulness of such a prognostic indicator in
clinical practice.
Pete Forster Fourth year medical student
Emma Heckford Fourth year medical student
Claire Huckler Fourth year medical student
Nicole Keong Fourth year medical student
Ahmed Al›Khabaz Fourth year medical student
Department of Epidemiology and Public Health,
School of Health Sciences, Medical School,
University of Newcastle, Newcastle upon Tyne
NE2 4HH
1 Gussekloo J, Westendorp RGJ, Remarque EJ, Lagaay AM,
Hereen TJ, Knook DL. Impact of mild cognitive
impairment on survival in very elderly people: cohort
study. BMJ 1997;315:1053›4. (25 October.)
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Decreased survival with cognitive
impairment seems not to be related to
comorbidity
Editor—Gussekloo et al showed an
increased mortality with increasing cogni›
tive impairment in a population of very old
subjects.1 Lower cognitive status in elderly
people may also be due to chronic disease,
and the risk of death might be entirely due
to concurrent chronic diseases rather than
to dementia. We investigated the effect of the
number of diseases and their severity on
mental state and survival in elderly patients.
We obtained data from the evaluation of
650 consecutive elderly patients on admis›
sion to a geriatric evaluation and rehabilita›
tion unit over a period of 14 months. A
standard protocol was used to assess demo›
graphic factors, mental and functional state,
and somatic health. Somatic health was
evaluated as the presence of 15 of the most
common diseases in elderly patients in hos›
pital and their severity. Severity was evalu›
ated by Greenfield’s individual disease
severity index, in which each condition was
graded from 0 (no disease) to 4 (greatest
severity of disease).2 We excluded patients
with terminal or wasting disease (renal or
liver failure, malignant neoplasm, diabetes,
or chronic inflammatory diseases).
Our population (mean age 79.2 (SD 7.4)
years; 456 women (70.2%)) had moderate
functional impairment (mean of 2.8 (2.0)
functions lost3), mild depression (mean gen›
eral depression score 13.0 (6.3)4), and many
diseases (mean 5.1 (2.7)). Overall, 113
patients died within 12 months after
discharge (annual death rate 17.4%).
Like Gussekloo et al, we identified four
subgroups with decreasing cognitive status
by using the mini›mental state examination.
The table shows the crude risk of death in
Cox’s proportional hazard survival analysis.
The severity of heart disease of ischaemic or
organic origin, heart disease of other origin,
respiratory disease, anaemia, malignancy,
and renal disease was independently associ›
ated with mortality; disability and serum
albumin concentration were also associated
with greater mortality (data not shown). The
table also shows that the association between
cognitive impairment and mortality held
after all confounders associated with mortal›
ity in the bivariate Cox’s model were
controlled for—that is, age, sex, severity of
diseases, disability, and serum albumin
concentration.
Gussekloo et al state that mental state
may act as an important predictor of
survival in elderly people. Although we did
not find a significant association between
mild cognitive impairment and mortality
(relative risk 1.8 (95% confidence interval
0.7 to 4.8)), our data are in line with their
conclusions supporting the need to assess
mental state to predict the survival of very
elderly people.
Renzo Rozzini Chief
Medical Unit for the Acute Care of the Elderly,
Poliambulanza Hospital, Brescia, Italy
Simone Franzoni Chief
Geriatric Evaluation and Rehabilitation Unit,
Richiedei Hospital, Gussago, Brescia
Giovanni B Frisoni Doctor
Marco Trabucchi Professor
Geriatric Research Group, 25122 Brescia
1 Gussekloo J, Westendorp RGJ, Remarque EJ, Lagaay AM,
Hereen TJ, Knook DL. Impact of mild cognitive
impairment on survival in very elderly people: cohort
study. BMJ 1997;315:1053›4. (25 October.)
2 Greenfield S, Blanco DM, Elashoff RM. Development and
testing of a new index of comorbidity. Clin Res
1987;35:346A.
3 Katz S, Downs TD, Cash HR Grotz RC. Progress in devel›
opment of the index of ADL. Gerontologist 1970;10(1):
20›30.
4 Brink TL, Yesavage JA, Lum O, Heersema PH, Adey M,
Rose TL. Screening tests for geriatric depression. Clin
Gerontol 1982;1:37›43.
5 Folstein MF, Folstein SE, McHugh PR. Mini›mental state: a
practical method for grading cognitive state of patients for
the clinician. J Psychiatr Res 1975;12:189›98.
Authors’ reply
Editor—The mini›mental state examina›
tion is widely used to screen for cognitive
impairment in (very) elderly people. We
emphasise that 40% of the participants of
the Leiden 85›plus study had optimal scores
of 28›30 points.1 As we described earlier,
elderly subjects with test scores of 28›30
points tend to have equal scores over a
period of three years.2 In contrast, subjects
with borderline scores of 24›27 points tend
to have lower scores over a similar period of
time. In our paper we showed that subjects
with borderline test scores have a higher risk
of mortality.
Whether these subtle differences in
scores on the mini›mental state examination
are due to differences in cognition is
debatable. However, test scores of 24›27
points and of 28›30 points undoubtedly dis›
tinguish different people. These findings are
confirmed by the observations of Rozzini et
al. Their data suggest that the increased risk
of mortality in subjects with borderline test
scores is not due to comorbidity. The risk
estimates were not materially different after
adjustment for concurrent chronic diseases
diagnosed in hospital. These observations
strengthen the role of mental state as an
important risk factor for mortality. Taken
together, we can conclude that the mini›
mental state examination is a valid instru›
ment to differentiate subjects at higher risk
at a cut off score of 27 points.
Forster et al doubt whether the mini›
mental state examination has similar predic›
tive properties when used by doctors in
clinical practice instead of the two research›
ers in the Leiden 85›plus study. We are con›
vinced that scores in the mini›mental state
examination are reproducible when the
instructions of the test are taken seriously.3
Indeed, the predictive value of a score for
one subject has to be weighted differently
from the predictive value of scores for a
group of subjects, but this dilemma holds for
every instrument used to screen for subjects
at high risk.4
J Gussekloo General practitioner
E J Remarque Research fellow
A M Lagaay Senior registrar
D L Knook Professor
Section of Gerontology and Geriatrics, Department
of General Internal Medicine, University Hospital
Leiden, P›3›Q , PO Box 9600, 2300 RC Leiden,
Netherlands
R G J Westendorp Senior registrar
Clinical Epidemiology Leiden, University Hospital
Leiden, Leiden
T J Heeren Professor
Department of Psychiatry, University of Utrecht,
Utrecht, Netherlands
1 Heeren TJ, Lagaay AM, van Beek WCA, Rooijmans HGM,
Hijmans W. Reference values for the mini›mental state
examination (MMSE) in octo› and nonagenarians. J Am
Geriatr Soc 1990;38:1093›6.
2 Izaks GJ, Gussekloo J, Dermout KMT, Heeren TJ, Ligthart
GJ. Three›year follow›up of mini›mental state examination
score in community residents aged 85 and over. Psychol
Med 1995;25:841›8.
3 Folstein MF, Folstein SE, McHugh PR. Mini›mental state: a
practical method for grading the cognitive state of patients
for the clinician. J Psychiatr Res 1975;12:189›98.
4 Wald NJ, Law M, Watt HC, Wu T, Bailey A, Johnson AM, et
al. Apolipoproteins and ischaemic heart disease: implica›
tions for screening. Lancet 1994;343:75›9.
Medical students may not like
statistics, but as doctors they will
Editor—In his book review, Wessely finds
Sinclair’s analysis of medical education in
Making Doctors depressing because Sinclair
reports that medical students regard the
psychiatrist as “the lowest form of medical
life.”1 Further, they do this because of the
very things of which Wessely is rightly
proud: psychiatrists’ use of a questioning,
multidisciplinary, evidence based, patient
centred approach.
Wesseley was shocked to read that “statis›
tics is above all the subject most disliked by
students.”1 This is no surprise to those of us
given the task of teaching it to them.
However, statistics teachers can console
themselves with the thought that this dislike
will not always be there, and that as these doc›
tors progress through their careers they will
find statistics of ever increasing relevance and
importance. The BMJ shows this clearly in the
research it publishes, in the large number of
statistical articles it carries, and in its statistical
refereeing.
Crude and adjusted associations of score on mini›mental state examination with mortality after
12 months in 650 elderly patients
Score Proportion of deaths Crude relative risk (95% CI)* Adjusted relative risk (95% CI)†‡
28›30 5/94 1.0 1.0
24›27 18/194 1.8 (0.7 to 4.9) 1.8 (0.7 to 4.8)
19›23 25/131 3.8 (1.5 to 10.0) 2.6 (1.0 to 6.9)
0›18 65/231 6.2 (2.5 to 15.4) 3.6 (1.4 to 9.2)
*P<0.0001 in test for trend with decreasing score.
†Adjusted for age, sex, severity of disease (ischaemic or organic heart disease, heart disease of other origin, respiratory
disease, kidney diseases, anaemia, and malignancy), serum albumin concentration, and disability.
‡P=0.003 in test for trend with decreasing score.
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When I was a student, the attitude to my
subject was: “Here’s to pure mathematics,
may it never be any use to anybody.” The
ultimate goal, now achieved, was the proof of
Fermat’s last theorem. I soon learnt that this
would not take me far in the outside world
and that being of use to people, and to doc›
tors in particular, was far more rewarding. In
the same way, Sinclair’s medical students will
learn that not all problems can be solved
with a scalpel.
We continue to grow after leaving full
time education. Given what Sinclair tells us,
this is just as well.
J Martin Bland Professor of medical statistics
Department of Public Health Sciences, St George’s
Hospital Medical School, London SW17 0RE
1 Wessely S. Medicine and books: Making doctors: an institu›
tional apprenticeship. BMJ 1998;316:713. (28 February.)
Effect of moderate alcohol
consumption on Lp(a)
lipoprotein concentrations
Reduction is supported by other studies
Editor—We agree with Paassilta et al that
there may be a relation between moderate
alcohol consumption and lower Lp(a)
lipoprotein concentrations.1 The relation
between alcohol consumption and cardio›
vascular mortality is U shaped, with the low›
est mortality at an alcohol consumption of
2›4 units (16›32 g) a day.2 Several mecha›
nisms contribute to this cardioprotective
effect including beneficial increases in high
density lipoprotein cholesterol3 and inhibi›
tion of platelet aggregation.4 However, other
factors may be involved. Lp(a) lipoprotein is
a recognised independent risk factor for the
development of atherosclerosis and, as
stated by Paassilta et al, little attention has
been directed to the effects of alcohol on
Lp(a) lipoprotein.
In 1995 we reported a significant reduc›
tion in Lp(a) lipoprotein concentration in a
prospective study of 20 healthy volunteers
(men and women) given 21 g of alcohol
daily for 10 days in the form of red wine
(median (range) 186 (15›1420) mg/l v 132
(10›1210) mg/l, P < 0.001).5 This reduction
was not repeated when the same subjects
were given white wine, raising the issue of
potential differences between various alco›
holic drinks. Interestingly, we found no
changes in high density lipoprotein choles›
terol concentrations.
We have conducted a larger unpub›
lished crossover trial in 50 men comparing
the effects of 3 units (24 g) of alcohol a day
as red wine or vodka for 14 days on Lp(a)
lipoprotein concentrations. Each period of
alcohol consumption was preceded by two
weeks’ abstinence. Both drinks produced a
10›12% decrease in Lp(a) concentration
(geometric mean 153 mg/100 ml v
135 mg/l after vodka, P < 0.001; 151 mg/l v
136 mg/l after red wine, P < 0.01). These
results suggest that moderate alcohol con›
sumption results in changes in Lp(a)
lipoprotein which are independent of the
type of alcoholic drink consumed. In
conclusion, we agree with Paassilta et al that
lower Lp(a) concentrations may be one fac›
tor conferring lower mortality and cardio›
vascular benefit in social drinkers.
Peter C Sharpe Senior registrar in clinical
biochemistry
Ian S Young Consultant in clinical biochemistry
Department of Clinical Biochemistry, Queens
University of Belfast and Royal Hospitals Trust,
Belfast BT12 6BA
Alun E Evans Professor of epidemiology
Division of Epidemiology, Queen’s University of
Belfast
1 Paassilta M, Kervinen K, Rantala AO, Savolainen MJ, Lilja
M, Reunanen A, et al. Social alcohol consumption and low
Lp(a) lipoprotein concentrations in middle aged Finnish
men: population based study. BMJ 1998;316:594›5.(21
February.)
2 Kannel WB, Ellison RC. Alcohol and coronary heart
disease—the evidence for a protective effect. Clin Chim Acta
1996;246:59›76.
3 Paunio M, Heinonen OP, Virtamo J, Klag MJ, Manninen V,
Albanes D, et al. HDL cholesterol and mortality in Finnish
men with special reference to alcohol intake. Circulation
1994;90:2909›18.
4 Renaud S, De Lorgeril M. Wine, alcohol, platelets and the
French paradox for coronary heart disease. Lancet
1992;339:1523›6.
5 Sharpe PC, McGrath LT, McClean E, Young IS, Archbold
GPR. Effect of red wine consumption on lipoprotein (a)
and other risk factors for atherosclerosis. Q J Med
1995;88:101›8.
No effect seen in Australian drinkers
Editor—Paassilta et al suggest that a
moderate intake of alcohol in Finnish men is
associated with a roughly 50% reduction in
median Lp(a) lipoprotein concentration.1
We have published relevant data from a
large Australian cohort participating in an
ongoing prospective study of cardiovascular
disease (2805 subjects >60 years, average
age 70 years).2 3
Current alcohol intake was assessed by
personal interview and classified as nil,
10›70 g/week, 80›140 g/week, 150›280 g/
week, and > 280 g/week (the last group in
men only). The third and fourth groups cor›
respond most closely with the middle and
highest third of alcohol intake described by
Paassilta et al.1 Lp(a) lipoprotein concentra›
tion was assessed by a sandwich enzyme
linked immunosorbentassay (ELISA) with
polyclonal sheep antibody raised against
purified human apo(a) (TintElize Lp(a)
Biopool, Sweden). The table shows median
(interquartile range) Lp(a) lipoprotein and
mean high density lipoprotein cholesterol
concentrations by sex and alcohol intake.
There was no significant relation
between Lp(a) lipoprotein concentration
and alcohol intake in either sex. We drew
similar conclusions when the data were
examined in those below or above 70 years
of age. The usual positive relation between
alcohol intake and high density lipoprotein
cholesterol was confirmed. Paassilta et al
examined only 259 men aged 40›60 years.
The median Lp(a) lipoprotein concentra›
tion in 37 teetotallers seemed high at 206
mg/l, and this may have been a spurious
result. Surprisingly, they found no relation
between alcohol intake and high density
lipoprotein cholesterol concentration.
Though we have reported that any alcohol
intake in our cohort is associated with
reduced coronary risk3 and raised Lp(a)
lipoprotein concentration is associated with
increased coronary risk,2 any link between
alcohol intake and Lp(a) lipoprotein con›
centration seems unlikely.
Leon A Simons Associate professor of medicine
Judith Simons Analyst›programmer
University of New South Wales, Lipid Research
Department, St Vincent’s Hospital, Darlinghurst,
NSW 2010, Australia
1 Paassilta M, Kervinen K, Rantala AO, Savolainen MJ, Lilja
M, Reunanen A, et al. Social alcohol consumption and low
Lp(a) lipoprotein concentrations in middle aged Finnish
men: population based study. BMJ 1998;316:594›5.
(21 February.)
2 Simons LA, Friedlander Y, McCallum J, Simons J. Risk fac›
tors for coronary heart disease in the prospective Dubbo
study of Australian elderly.Atherosclerosis 1995;117:107›18.
3 Simons LA, McCallum J, Friedlander Y, Simons J. Alcohol
intake and survival in the elderly: a 77 month follow›up on
the Dubbo study. Aus NZ J Med 1996;26:662›70.
Reduction is not found in women
Editor—Paassilta et al showed a quantita›
tive association between social alcohol
consumption and low Lp(a) lipoprotein
concentrations in middle aged men.1 As they
indicated, we reported a negative qualitative
association between drinking habits and
Lp(a) lipoprotein concentrations in men.2
We report here the results of a quantitative
analysis of the association between alcohol
intake and Lp(a) lipoprotein concentration
in the Jichi Medical School cohort study.
During 1992›5 we collected population
based data in rural districts in Japan. The
9532 subjects (3658 men and 5874 women),
which included all subjects in our previous
report, were divided into five categories by
drinking status; non›drinkers, (963 men),
former drinkers (140 men), drinkers in the
lowest third of alcohol intake ( < 107 g/
week; 711 men), drinkers in the middle third
(107›224 g/week; 942 men), and drinkers in
the highest third ( > 224 g/week; 902 men).
Serum Lp(a) lipoprotein concentrations
were measured with an enzyme linked
Median (interquartile range) Lp(a) lipoprotein and mean high density lipoprotein (HDL) cholesterol














0 262 90 (40›255) 1.12 739 115 (50›275) 1.37
10›70 425 100 (40›240) 1.16 570 125 (60›310) 1.45
80›140 266 103 (45›280) 1.29 197 125 (45›310) 1.62
150›280 160 88 (45›230) 1.39 42 125 (65›260) 1.70
>280 97 85 (35›205) 1.42 › › ›
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immunosorbent assay (ELISA) and Lp(a)
lipoprotein and triglyceride concentrations
were calculated as geometric means. We
used SAS software for statistical analysis.
The groups were similar regarding body
mass index and total cholesterol concentra›
tions. The mean age of former drinkers was
higher than that of men in the other groups
(analysis of variance P < 0.0001). We there›
fore adjusted for age in all other analyses.
Lp(a) lipoprotein concentration decreased
with increased alcohol consumption in men
except in former drinkers (table). Fibrino›
gen concentrations fell with increasing alco›
hol consumption (P < 0.05).
For women the geometric mean Lp(a)
concentrations were 148 mg/l in non›
drinkers, 144 mg/l in former drinkers,
144 mg/l in lowest third, 136 mg/l in
middle third, and 138 mg/l in highest third.
There was no significant association
between Lp(a) lipoprotein concentration
and alcohol consumption (P = 0.27).
Fibrinogen concentrations decreased with
increasing consumption (P < 0.0001).
Our analysis shows a negative relation
between alcohol consumption and and
Lp(a) lipoprotein concentrations in men but
not in women. These results support




Naoki Nago Visiting lecturer
Department of Community and Family Medicine,
Jichi Medical School, Minamikawachi, Kawachi,
Tochigi, Japan
1 Paassilta M, Kervinen K, Rantala AO, Savilainen MJ, Lilja
M, Reunanen A, et al. Social alcohol consumption and low
Lp(a) lipoprotein concentrations in middle aged Finnish
men: population based study. BMJ 1998;316:594›5.
(21 February.)
2 Nago N, Kyaba K, Hiraoka J, Matsuo H, Goto T, Kario K, et
al. Lipoprotein(a) levels in the Japanese population: influ›
ence of age and sex, and relation to atherosclerotic risk
factors. Am J Epidemiol 1995;141:815›21.
Information “Nuggets” are not
easy to find quickly
Editor—An essential ingredient in the
practice of evidence based medicine is the
evidence, but where can it be found? My
recent experience using Medline and
Embase suggests that these databases are
not the place for a busy general practitioner
to seek evidence with which to answer clini›
cal questions. Only 40%›46% of a physician’s
clinical questions can be answered using
Medline,1 2 and many of the citations
retrieved in a Medline search are irrelevant.3
Evaluated databases such as the Cochrane
database and Best Evidence are more
helpful to me than the raw, undigested
research that is available from Medline, but
even they are not concise enough to use eas›
ily to answer a particular clinical question.
Slawson and Shaughnessy suggested
that doctors are seeking “patient oriented
evidence that matters (POEM).”4 When
faced with a clinical question I would like
information NUGGETS. I want information
Now, Up to date, Grounded in Good
Evidence, There (on my desk), and Specific
to the problem. Where can I find a system
that will deliver information NUGGETS?
Nimmi Naidoo General practitioner
Nuffield Health Centre, Witney, Oxfordshire
OX8 7HQ
1 Osheroff JA, Bankowitz RA. Physicians’ use of computer
software in answering clinical questions. Bull Med Libr
Assoc 1993;81:11›9.
2 Gorman PN, Ash J, Wykoff L. Can primary care physicians’
questions be answered using the medical journal
literature? Bull Med Libr Assoc 1994;82:140›6.
3 Haynes RB, McKibbon A, Walker CJ, Ryan N, Fitzgerald D,
Ramsden MF. Online access to Medline in clinical settings.
Ann Int Med 1990;112:78›84.
4 Slawson DC, Shaughnessy AF. Obtaining useful informa›
tion from expert based sources. BMJ 1997;314:947›9.
Interventions to treat shoulder
pain
Review was overly negative
Editor—The systematic review by Green
and colleagues of interventions for treating
shoulder pain concluded that there is little
evidence to support the use of any of the
common interventions for the management
of shoulder pain.1 This is a negative message
that is likely to inhibit practitioners from
treating patients with shoulder pain and to
dissuade them from referring these patients
to specialists. While we agree with the other
conclusions of the study, we disagree with
the negative message about treatment for
several reasons.
Rheumatologists make decisions about
the treatment of musculoskeletal disorders
such as shoulder pain based on the duration
of the condition, its severity, and a careful
examination to define the exact site of the
lesion.2 It is generally taught, for example,
that the injection of corticosteroids will only
work if done soon after the onset of any
shoulder disorder and if the injection has
been precisely localised to the anatomical
site of the problem, such as a specific tendon
or bursa within the rotator cuff.3 In the
systematic review of the evidence great
weight was given to the quality of the studies,
but no weight was given to the quality of the
clinical input to the studies, or to any of the
three clinical criteria described above.
We would agree that the assessment of
the value of treatments for shoulder pain is
difficult because of the overall poor quality
of published studies, the absence of agreed
outcome measures, and a lack of uniformity
of definitions; some recent rheumatological
research has addressed the problem of defi›
nitions.4 However, the methods used to
assess quality in this review are not transpar›
ent or validated, and it is unclear on what
basis the authors chose to combine studies;
this throws into question the validity of their
conclusions.
Furthermore, if, as the authors of this
and other reviews of interventions to treat
shoulder pain contend, the methodological
scores for most studies are low, surely it is
erroneous to conclude that treatments do
not work. The poor quality of the evidence
discredits the negative conclusions as well as
the positive ones.
Bela Szebenyi Consultant rheumatologist
National Institute of Rheumatology and
Physiotherapy, H›1525, Budapest 114, Hungary
Paul Dieppe Director
Medical Research Council Health Services
Research Collaboration, University of Bristol,
Bristol BS8 2PR
1 Green S, Buchbinder R, Glazier R, Forbes A. Systematic
review of randomised controlled trials of interventions for
painful shoulder: selection criteria, outcome assessment,
and efficacy. BMJ 1998;316:354›60. (31 January.)
2 Szebenyi B. Non›pharmacological approaches to pain
management: can drugs be avoided? In: Pain in
musculoskeletal diseases: new concepts for an age›old question.
XIX ILAR congress of rheumatology, Singapore 1997. Hong
Kong: Excerpta Medica, 1998.
3 Dalton S. The shoulder. In: Klippel J, Dieppe P, eds. Rheu›
matology. 2nd ed. London: Mosby, 1998.
4 Pope DP, Croft PR, Pritchard CM, Silman AJ. Prevalence of
shoulder pain in the community: the influence of case
definition. Ann Rheum Dis 1997;56:308›12.
Lack of concordance between
rheumatologists may render multicentre
studies invalid
Editor—As Green et al point out the man›
agement of shoulder pain is bedevilled by
imprecise diagnostic criteria.1 It is likely that
many trials that examine the efficacy of
treatment are flawed because treatment has
been directed at the wrong part of the
shoulder mechanism.
As there are only three joints and two
main tendons in the shoulder it ought not
be too difficult to agree a simple set of
Mean atherosclerotic risk factors by alcohol consumption for men in the Jichi Medical School study, 1992›5
Non›drinker Former drinker <107 g/week 107›224 g/week >224 g/week
No Mean No Mean No Mean No Mean No Mean P value†
Age (years) 963 57.5 140 61.3 711 54.8 942 53.9 902 54.9 <0.0001
Body mass index (kg/m2) 958 22.9 138 23.1 703 23.1 941 22.9 898 22.9 0.74
Lp(a) lipoprotein (mg/l)* 963 135 140 120 711 129 942 128 902 107 <0.0001
Fibrinogen (g/l) 570 2.46 97 2.55 530 2.42 713 2.42 643 2.38 <0.05
*Geometric means were calculated for Lp(a).
†P values for variables except age were calculated after adjustment for age by analysis of covariance.
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diagnoses with appropriate signs. But this is
not enough. Our own study showed that
three consultant rheumatologists who
examined the same patients disagreed on
the precise diagnosis in over 50% (14/26) of
the cases, and when they examined a second
group of patients together (so that they
agreed on the clinical signs) they still
disagreed in nearly 20% (4/18) of the cases.2
Such a lack of concordance among clini›
cians who are experienced in the manage›
ment of shoulder problems will render any
multicentre study invalid, and may leave any
study by an individual clinician open to
doubt or criticism.
Andrew Bamji Consultant rheumatologist
Department of Rheumatology, Queen Mary’s
Hospital, Kent DA14 6LT
1 Green S, Buchbinder R, Glazier R, Forbes A. Systematic
review of randomised controlled trials of interventions for
painful shoulder: selection criteria, outcome assessment,
and efficacy. BMJ 1998:316:354›60. (31 January.)
2 Bamji AN, Erhardt CC, Price TR, Williams PL. The painful
shoulder: can consultants agree? Br J Rheumatol
1996;35:1172›4.
Authors’ reply
Editor—Szebenyi and Dieppe have
adopted an overly pessimistic reaction to
our paper by misquoting our conclusions.
The abstract and the further research
section clearly state that “there is little
evidence to either support or refute the effi›
cacy of common interventions for shoulder
pain.”
The suggestion that careful clinical
assessment will identify the problem is ques›
tionable. As Bamji points out, one of the
important findings of our study (and his
own), is a lack of concordance in the
labelling and defining of shoulder disorders.
This presents difficulties for those perform›
ing clinical trials as well as for clinicians who
rely on the results to manage their patients.
It is also of concern for those who use data›
bases to make inferences about these condi›
tions.1 The need for formal development
and universal adoption of valid and reliable
criteria for classifying shoulder disorders
has been highlighted previously.2
Teaching students that the injection of
corticosteroids will only work if done shortly
after the onset of symptoms and if the injec›
tion has been precisely localised does not
seem to be based on any evidence. One
problem is the inability to precisely localise
the injection. Previous studies have sug›
gested that as many as 60% of shoulder
injections thought to be intra›articular may
not be.3 4
The methods we used to assess meth›
odological quality have been well validated
and are described in the reference cited in
the review.5 Complete details will shortly be
available from the Cochrane Library Muscu›
loskeletal Group. The overall score of meth›
odological quality was calculated based on
an assessment of the study population
(selection criteria, randomisation, compa›
rable control group, and complete follow
up), description of the intervention, meas›
urement of the effect (blinding of patient
and assessor, outcome measures), and data
analysis (including complete presentation of
results and consideration of sample size).
The criteria used to combine the studies is
specified in the methods section. Trials con›
sidered for pooling were those in which the
same intervention was used in similar popu›
lations and in which the same outcome
measure was used at similar lengths of
follow up.
Further clinical trials are needed to
determine optimal treatment strategies for
shoulder pain. While such trials have the
potential to be bedevilled by problems of
diagnostic criteria, unlike Bamji we believe
that careful consideration of selection
criteria and outcome measures are not
insurmountable challenges.
Rachelle Buchbinder Senior lecturer in clinical
epidemiology
Sally Green PhD scholar
Andrew Forbes Senior lecturer in biostatistics
Department of Epidemiology and Preventive
Medicine, Monash University, Melbourne 3186,
Australia
Richard Glazier Assistant professor
Family and Community Medicine, Preventive
Medicine and Biostatistics, University of Toronto,
Ontario, Canada
1 Buchbinder R, Goel V, Bombardier C. The lack of
concordance between the ICD›9 classification of soft tissue
disorders of the neck and upper limb and chart review
diagnosis: one steel mill’s experience. Am J Ind Medicine
1996;29:171›82.
2 Buchbinder R, Goel V, Bombardier C. Classification
systems of soft tissue disorders of the neck and upper limb:
do they satisfy methodological guidelines? J Clin Epidemiol
1996;49:141›9.
3 Jones A, Regan M, Ledingham J, Pattrick M, Manhire A,
Doherty M. Importance of placement of intra›articular
steroid injections. BMJ 1993;307:1329›30.
4 Eustace J, Brophy D, Gibney R, Bresnihan B, Fitzgerald O.
Comparison of the accuracy of steroid placement with
clinical outcome in patients with shoulder symptoms.
Arthritis Rheum 1995;38:S249.
5 Glazier R, Buchbinder R, Bell M. Critical appraisal of con›
tinuing medical education in the rheumatic diseases for
primary care physicians. Arthritis Rheum 1995;38:533›8.
Suspension of consultant raises
serious issues
Editor—The recent news item1 and the
subsequent letter and correction2 about the
hearing of Dr James Taylor before the Gen›
eral Medical Council have not taken account
of some serious issues raised by this case,
which will affect interventional physicians,
cardiologists, and radiologists as well as
obstetricians, surgeons, and others.
The accusation had been about consent,
not of medical negligence. Negligence forms
no part of the hearing. At issue was the
extent to which consent is covered in the
standard consent form used in NHS
hospitals. After lengthy debate by counsel
both for the GMC and Dr Taylor, the GMC’s
legal adviser omitted the strong legal
challenge by defending counsel. He relied
on his interpretation of two previous,
distinctly different, cases reviewed by the
Privy Council.
It was accepted that “consent” may not
be required if the medical action was “neces›
sary, in the child’s best interest, and
medically justified.” However, the GMC
panel ruled that “necessary” meant “imme›
diately life›threatening.” It came to this con›
clusion on the basis of a “Guide to Consent”
published by the NHS in 1991, and of legal
precedents, which concerned adult patients
of unsound or immature mind. The
unanimous expert evidence in the present
case was that the procedure undertaken had
been fully justified, a crucial point totally
ignored in the GMC’s decision.
In all its hearings the GMC panel acts as
both jury and judge—the strictly legal part
being in the hands of its legal adviser, who
pronounces on legal issues and precedent.
His opinion is not questioned by the panel
and is not open to challenge. This adviser is
part of the panel—that is, not an independ›
ent judge.
Decisions at these hearings as to fact
should be proved “beyond reasonable
doubt.” Yet these proceedings were con›
ducted in a manner that seemed to require
the defendant to prove himself to be
innocent. The finding of “guilty of serious
professional conduct” seems to go against
the legitimate and admitted doubt concern›
ing the implications of the consent. If the
GMC wished to clarify consent, it could do
so by issuing firm regulations (which it has
so far failed to do), rather than by penalising
one doctor.
Siding with the parents on the issue of
consent, the GMC may make it impossible
for doctors caring for children to act “first
and always” (as the motto of the Great
Ormond Street children’s hospital states) in
the interest of the child, whenever an
unexpected and urgent procedure ought to
be performed.
As matters now stand, doctors may be
prevented from acting in the patient’s best
interest when the unforeseen arises and
requires immediate attention.
There is no appeal to the GMC’s
decision, other than to the Privy Council.
Should there not be an appeals procedure
within the GMC?
Gerald Graham Retired consultant clinical
physiologist
Whaddon, Buckinghamshire MK17 0LT
Tony Robinson Retired general practitioner
5 Valley Forge Drive, Tonbridge, Kent TN10 4EU
1 Dyer, C, Consultant suspended for not getting consent for
cardiac procedure. BMJ 1998;316:955. (28 March.)
2 Goodwin JF, Somerville W. Punishment of doctors must fit
their crime [correction appears in BMJ 1998;316:1677].
BMJ 1998;316:1248. (18 April.)
Correction
Punishment of doctors must fit their crime
An authors’ error occurred in this letter by
Goodwin and Somerville. At the hearing the
parents, both in their evidence and through
their counsel, accused Dr Taylor not only of
having acted without consent but also of
actually having proceeded against their
(allegedly previously expressed) wish. This
part of their action, however, failed (contrary
to the statement made in Goodwin and
Somerville’s letter).
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